We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 63.00 | 61.00 | 65.00 | 63.00 | 63.00 | 63.00 | 14,893 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1M | -3.09M | -0.1312 | -4.80 | 14.85M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/5/2015 08:54 | Bought TUNG at 90P for a trade, this were £1.15p 2 days ago and £3+ a few months ago | 65jack | |
29/5/2015 08:51 | I,M BACK IN @1.77 | falia | |
29/5/2015 08:49 | Luminiso At least a dozen people knows this from 55p. They were told to keep their lips tight BR does not post too post on his little gems/ from 55p. He likes to buy buy buy for himself. There are a few bluey who can vouch for this :), only selected folks in the close circle luminoso 29 May'15 - 08:45 - 191 of 192 0 0 BR, you are a great short term trader, no doubt about it, but pharma investing expert ? Not so sure. | bad robot | |
29/5/2015 08:47 | WHAT IS NEXT ENTRY POINT , I THINK 160 | falia | |
29/5/2015 08:46 | Falia Nah. I leave some for the next man. If they want to trade this, good luck . I got my 60% and grateful to the Market.. | bad robot | |
29/5/2015 08:45 | BR, you are a great short term trader, no doubt about it, but pharma investing expert ? Not so sure. | luminoso | |
29/5/2015 08:44 | BR WHAT ARE YOU SAY | falia | |
29/5/2015 08:43 | FDA fast track without the trial has started??? FAST TRACK tends to be Phase III, NSCI has not even started phase II | bad robot | |
29/5/2015 08:41 | shake over back in BR | falia | |
29/5/2015 08:39 | The FDA Fast Track Designation is a designation of the United States Food and Drug Administration (FDA) that facilitates the development, and expedites the review, of drugs which treat a serious or life-threatening condition and fill an unmet medical need. Fast Track designation must be requested by the drug company. The request can be initiated at any time during the drug development process. FDA will review the request and attempt to make a decision within sixty days. | bamboo2 | |
29/5/2015 08:37 | Hyper AL Phase II takes 2-3 years mate. I am a pharma's shares King | bad robot | |
29/5/2015 08:34 | BCKTTSIM many thanks for that info, have you a link with the information about them owning 20%? many thanks | rugby | |
29/5/2015 08:32 | Anyway goodluck. Each one to himself / herself. IN BR WE TRUST | bad robot | |
29/5/2015 08:32 | Look at cheap advfn chart can you honestly see 250p? or any further rise possible | bad robot | |
29/5/2015 08:30 | Tecnically impossible. Check RSI where it's trading. at 205- 209, RSI was 98, that's about when my sell signal kicked off | bad robot | |
29/5/2015 08:28 | RugbyThis company owns upto 20% of a ground breaking treatment for cancer that will do away with the need to do surgery for many patients. It's going to be worth billions.Not much ! | bckttsim | |
29/5/2015 08:28 | Good luck chaps. I am off to my next 60%+ for the day. I may buy back here if I get 140p | bad robot | |
29/5/2015 08:26 | To get to some normality the trading range, should be about 160p-162p today | bad robot | |
29/5/2015 08:22 | C'mon the chasers bought after 35% rise to 56%, what do they expect. No one was touching this at 135p yesterday. Only AL & I posted here | bad robot | |
29/5/2015 08:21 | No information to base this silly rise on at all. This will sink believe me. | rugby | |
29/5/2015 08:20 | not looking good, mms buying shares at 10% discount for amount greater than 2.5K :( | bad robot |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions